Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Farnesoid X receptor agonists

Farnesoid X receptor agonists

US Patent 8158665 · Granted Apr 17, 2012

Estimated economic value: $39,460,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Indazole compounds as mGluR4 allosteric potentiators, compositions, and methods 2025
Compounds and uses thereof2024
Benzoylglycine derivatives and methods of making and using same2024
Indazole compounds as MGLUR4 allosteric potentiators, compositions, and methods 2022
Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, an2022
Chemical compounds as H—PGDS inhibitors2021
Positive allosteric modulators of the muscarinic acetylcholine receptor M42021
Heteroaryl compounds as BTK inhibitors and uses thereof2021
1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostag2021
Benzoylglycine derivatives and methods of making and using same2021
Positive allosteric modulators of the muscarinic acetylcholine receptor M42021